- Home
- FOLD vs HHH Comparison
FOLD vs HHH Comparison
Compare FOLD & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOLD | HHH |
|---|---|---|
| Founded | 2002 | 2010 |
| Country | United States | United States |
| Employees | N/A | 500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.7B |
| IPO Year | 2006 | 2023 |
Fundamental Metrics
Financial Performance| Metric | FOLD | HHH |
|---|---|---|
| Price | $14.40 | $61.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $27.25 | ★ $90.00 |
| AVG Volume (30 Days) | ★ 3.0M | 543.2K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ 2.21 |
| Revenue | N/A | ★ $1,474,892,000.00 |
| Revenue This Year | $20.50 | $14.04 |
| Revenue Next Year | $18.59 | N/A |
| P/E Ratio | ★ N/A | $28.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.66 | $61.41 |
| 52 Week High | $14.39 | $91.07 |
Technical Indicators
Market Signals| Indicator | FOLD | HHH |
|---|---|---|
| Relative Strength Index (RSI) | 71.09 | 24.66 |
| Support Level | $14.21 | N/A |
| Resistance Level | N/A | $71.26 |
| Average True Range (ATR) | 0.02 | 1.68 |
| MACD | -0.02 | -0.31 |
| Stochastic Oscillator | 87.50 | 0.11 |
Price Performance
Historical ComparisonAbout FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc, through its subsidiary, operates a large-scale, mixed-use real estate platform focused on the development of master planned communities (MPCs), the investment in strategic real estate development opportunities, and the ownership and operation of income-producing properties. The group operates through three reportable business segments: Operating Assets, MPCs, and Strategic Developments. Maximum revenue is generated from the MPC segment, which consists of the development and sale of land in large-scale, long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. Revenues are mainly generated through the sale of residential and commercial land to homebuilders and developers.